Coherus Biosciences | CHRS - Stock


Coherus Biosciences reported $3.17M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
AbbVie USD 5.05B 98M Mar/2026
Acadia Pharmaceuticals USD 31.57M 3.1M Mar/2026
Akebia Therapeutics USD 13M 2.61M Mar/2026
ALKERMES USD 336.7M 140.08M Mar/2026
Alnylam Pharmaceuticals USD 200.15M 117.43M Mar/2026
Amarin USD 183.58M 12.32M Mar/2026
Amgen USD 6.19B 39M Mar/2026
Baxter International USD 2.32B 84M Mar/2026
Biogen USD 1.95B 219.1M Mar/2026
BioMarin Pharmaceutical USD 1.27B 25.66M Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Coherus Biosciences USD 3.17M 1.12M Dec/2025
Eli Lilly USD 14.53B 785M Mar/2026
Fujifilm JPY 600.12B 1.55B Sep/2025
Gilead Sciences USD 1.91B 140M Mar/2026
Merck USD 6.48B 179M Mar/2026
Myriad Genetics USD 27.9M 2.7M Mar/2026
Pacira USD 150.37M 2.49M Mar/2026
Perrigo USD 1.12B 27.6M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
PTC Therapeutics USD 75.57M 4.08M Mar/2026
Regeneron Pharmaceuticals USD 3.1B 97.2M Mar/2026
Sarepta Therapeutics USD 1B 86.37M Mar/2026
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
Vertex Pharmaceuticals USD 1.77B 79.9M Mar/2026
Zoetis USD 2.55B 120M Mar/2026